Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates
Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates
About this item
Full title
Author / Creator
Publisher
United States: Copyright Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Copyright Oxford University Press
Subjects
More information
Scope and Contents
Contents
Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare bone disorder commonly treated with bisphosphonates, but clinical and biochemical responses may be incomplete.
To evaluate the efficacy and tolerability of the receptor activator of nuclear factor-κB ligand inhibitor denosumab in the treatment of patients with FD/MAS refractory to bis...
Alternative Titles
Full title
Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2364240347
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2364240347
Other Identifiers
ISSN
0021-972X
E-ISSN
1945-7197
DOI
10.1210/jc.2018-02543
